Cargando…

Dysregulation of microRNA expression drives aberrant DNA hypermethylation in basal-like breast cancer

Basal-like breast cancers frequently express aberrant DNA hypermethylation associated with concurrent silencing of specific genes secondary to DNMT3b overexpression and DNMT hyperactivity. DNMT3b is known to be post-transcriptionally regulated by microRNAs. The objective of the current study was to...

Descripción completa

Detalles Bibliográficos
Autores principales:	SANDHU, RUPNINDER, RIVENBARK, ASHLEY G., MACKLER, RANDI M., LIVASY, CHAD A., COLEMAN, WILLIAM B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2013
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898722/ https://www.ncbi.nlm.nih.gov/pubmed/24297604 http://dx.doi.org/10.3892/ijo.2013.2197

Ejemplares similares

Loss of post-transcriptional regulation of DNMT3b by microRNAs: A possible molecular mechanism for the hypermethylation defect observed in a subset of breast cancer cell lines
por: SANDHU, RUPNINDER, et al.
Publicado: (2012)

DNMT3b overexpression contributes to a hypermethylator phenotype in human breast cancer cell lines
por: Roll, J Devon, et al.
Publicado: (2008)

Identification of Dysregulated microRNAs in Glioblastoma Stem-like Cells
por: Evers, Lara, et al.
Publicado: (2023)

Endometrial Cancer and Hypermethylation: Regulation of DNA and MicroRNA by Epigenetics
por: Banno, Kouji, et al.
Publicado: (2012)

Dysregulation of MicroRNAs in cancer
por: Chen, Pai-Sheng, et al.
Publicado: (2012)

Aberrant Expression of Circulating MicroRNA Leads to the Dysregulation of Alpha-Synuclein and Other Pathogenic Genes in Parkinson’s Disease
por: Cai, Meng, et al.
Publicado: (2021)

MicroRNA dysregulation in multiple sclerosis
por: Jr, Omar de Faria, et al.
Publicado: (2013)

MicroRNA regulation and dysregulation in epilepsy
por: Dogini, Danyella B., et al.
Publicado: (2013)

MicroRNA Dysregulation in Cystic Fibrosis
por: McKiernan, Paul J., et al.
Publicado: (2015)

MicroRNA Dysregulation in Prostate Cancer
por: Schitcu, Vlad Horia, et al.
Publicado: (2022)

The Differential DNA Hypermethylation Patterns of microRNA-137 and microRNA-342 Locus in Early Colorectal Lesions and Tumours
por: Kashani, Elham, et al.
Publicado: (2019)

MicroRNAs as Molecular Biomarkers for the Characterization of Basal-like Breast Tumor Subtype
por: Tariq, Muhammad, et al.
Publicado: (2023)

Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in cervical cancer
por: Yao, Tingting, et al.
Publicado: (2013)

Aberrant CpG Islands Hypermethylation Profiles in Malignant Gliomas
por: Kim, Kwang Ryeol, et al.
Publicado: (2014)

HOXA11 gene is hypermethylation and aberrant expression in gastric cancer
por: Bai, Yinguo, et al.
Publicado: (2014)

Erratum: microRNA dysregulation in multiple sclerosis
por: Moore, Craig S., et al.
Publicado: (2013)

Epigenetic alteration and microRNA dysregulation in cancer
por: Suzuki, Hiromu, et al.
Publicado: (2013)

Pathogenic Role of MicroRNA Dysregulation in Podocytopathies
por: Liu, Feng, et al.
Publicado: (2022)

Modulatory Role of microRNAs in Triple Negative Breast Cancer with Basal-Like Phenotype
por: Angius, Andrea, et al.
Publicado: (2020)

Clinical significance of promoter region hypermethylation of microRNA-148a in gastrointestinal cancers
por: Sun, Jingxu, et al.
Publicado: (2014)

Downregulation of microRNA-132 by DNA hypermethylation is associated with cell invasion in colorectal cancer
por: Qin, Jun, et al.
Publicado: (2015)

The Impact of Dysregulated microRNA Biogenesis Machinery and microRNA Sorting on Neurodegenerative Diseases
por: Weng, Yu-Ting, et al.
Publicado: (2023)

The role of aberrant promoter hypermethylation of DACT1 in bladder urothelial carcinoma
por: Cheng, Huan, et al.
Publicado: (2012)

Genomic insights into cancer-associated aberrant CpG island hypermethylation
por: Sproul, Duncan, et al.
Publicado: (2013)

Aberrant Promoter Hypermethylation of RASSF Family Members in Merkel Cell Carcinoma
por: Richter, Antje M., et al.
Publicado: (2013)

Immune pressures drive the promoter hypermethylation of neoantigen genes
por: Yi, Ming, et al.
Publicado: (2019)

Comparative microRNA profiling of sporadic and BRCA1 associated basal-like breast cancers
por: Yan, Max, et al.
Publicado: (2015)

CpG island hypermethylation-associated silencing of microRNAs promotes human endometrial cancer
por: Li, Bi-Lan, et al.
Publicado: (2013)

MicroRNA-421 Dysregulation is Associated with Tetralogy of Fallot
por: Bittel, Douglas C., et al.
Publicado: (2014)

Dysregulated MicroRNA Expression in Irritable Bowel Syndrome
por: Park, Jung Ho
Publicado: (2016)

Zinc intake, microRNA dysregulation, and esophageal cancer
por: Fong, Louise Y., et al.
Publicado: (2016)

Identification of dysregulated microRNAs in canine malignant melanoma
por: Ushio, Norio, et al.
Publicado: (2019)

MicroRNA dysregulation influences growth hormone signaling
por: Elias, Amy E., et al.
Publicado: (2019)

MicroRNA Dysregulation in Cutaneous Squamous Cell Carcinoma
por: García-Sancha, Natalia, et al.
Publicado: (2019)

MicroRNAs Dysregulation and Mitochondrial Dysfunction in Neurodegenerative Diseases
por: Catanesi, Mariano, et al.
Publicado: (2020)

Dysregulated CD4+ T Cells and microRNAs in Myocarditis
por: Wang, Jing, et al.
Publicado: (2020)

MicroRNAs Dysregulation and Metabolism in Multiple System Atrophy
por: Xiang, Chunchen, et al.
Publicado: (2019)

Emerging Roles of Dysregulated MicroRNAs in Myasthenia Gravis
por: Wang, Lin, et al.
Publicado: (2020)

Dysregulation of microRNA and Intracerebral Hemorrhage: Roles in Neuroinflammation
por: Kashif, Hisham, et al.
Publicado: (2021)

Information on dysregulation of microRNA in placenta linked to preeclampsia
por: Nuh, Abdifatah Mohamed, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kn2ij6v2fgdkn475cdupijej5p